Once again, robotics contributed to revenue growth in the orthopedics market in Q221 and competition continues to heat up with several regulatory clearances and other developments from new market entrants in the quarter. Aside from robotics, enabling technology including intra-operative augmented reality, preoperative planning and navigation reached a number of milestones in Q221 across all indications in total joint replacement.
Among the many topics, including company revenues, market shares, charts and expert analysis, covered in the comprehensive Q221 CAS Ortho Market Recap* are:
The Q221 WW CAS Ortho market was up, as was the US ortho robotics market, according to SmartTRAK Financial Dashboard. Stryker (SYK) remained the market leader with ~75% share, followed by Smith & Nephew (SNN), Zimmer Biomet (ZBH) and other enabling tech competitors. For more detailed Q221 revenues and shares by company in the US, EU and ROW, see SmartTRAK CAS Ortho Financial Dashboard ...
*The entire article, including revenue, shares and links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.